Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease
5770 ajcn9130786.pdf (140.5Kb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
Hatoum, Ida J.
Nelson, Jeanenne J.
Cook, Nancy R.
Hu, Frank B.
Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600
MetadataShow full item record
CitationHatoum, Ida J, Jeanenne J Nelson, Nancy R Cook, Frank B Hu, and Eric B Rimm. 2010. “Dietary, Lifestyle, and Clinical Predictors of Lipoprotein-Associated Phospholipase A2 Activity in Individuals without Coronary Artery Disease.” The American Journal of Clinical Nutrition 91 (3): 786–93. https://doi.org/10.3945/ajcn.2009.28870.
AbstractBackground: Elevated lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) may be positively associated with risk of coronary artery disease, yet little is known about potentially modifiable factors related to Lp-PLA(2). Objective: The aim of this study was to determine dietary, lifestyle, and clinical measures associated with Lp-PLA(2) activity. Design: We measured Lp-PLA(2) activity in 853 female participants of the Nurses' Health Study and 878 male participants of the Health Professionals Follow-Up study who were free of cancer and cardiovascular disease. Multivariable linear regression models were used to assess the relation between potentially modifiable factors and Lp-PLA(2). Results: The replacement of 5% of energy from carbohydrates with energy from protein was associated with 2.2 nmol.min(-1).mL(-1) lower levels of Lp-PLA(2) (95% CI: -3.1, -0.4) activity, and every 15-g/d increase in alcohol consumption was associated with 4.4 nmol.min(-1).mL(-1) lower levels of Lp-PLA(2) activity (95% CI: -6.4, -2.4). Smoking (beta = 10.2; 95% CI: 4.8, 15.5), being overweight (beta = 7.5; 95% CI: 3.6, 11.3), aspirin use (beta = 6.0; 95% CI: 2.1, 10.0), hypercholesterolemia (beta = 15.0; 95% CI: 11.3, 18.8), and age (beta = 2.5; 95% CI: 1.34, 3.74) were associated with elevated Lp-PLA(2) activity, whereas postmenopausal hormone use (beta = -15.8; 95% CI: -19.4, -12.1) and cholesterol medication use (beta = -9.6; 95% CI: -18.2, -1.1) were inversely associated. Conclusion: We found that not smoking, use of postmenopausal hormones, having a body mass index (in kg/m(2)) <= 25, increased alcohol consumption, and increased protein consumption all represent potential modifiable factors that may favorably influence Lp-PLA(2) activity. Am J Clin Nutr 2010; 91: 786-93.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41247236
- SPH Scholarly Articles